The document summarizes the vicious cycle between diarrhea and malnutrition and its lasting effects on growth, development, and health. It discusses:
1. How diarrhea increases the risk and duration of malnutrition, and malnutrition in turn increases the risk and duration of diarrhea.
2. Evidence that early childhood diarrhea is associated with stunting, impaired cognition, and reduced school performance that can persist into adulthood.
3. Potential long-term effects of early infections and stunting on risks for obesity, diabetes, and cardiovascular disease later in life.
Epidemiology of Childhood Malnutrition in India and strategies of controlsourav goswami
This presentation includes the epidemiology of childhood malnutrition in India. the problems and challenges that are being faced in the improvement of the condition and the different strategies for its control.
Severe Acute Malnutrition (SAM) and Nutrition Rehabilitation Centre (NRC)- Dr...Yogesh Arora
A presentation on severe acute malnutrition and nutritional rehabilitation center. Various preventive, promotive, and curative aspects of SAM are discussed in this presentation.
Epidemiology of Childhood Malnutrition in India and strategies of controlsourav goswami
This presentation includes the epidemiology of childhood malnutrition in India. the problems and challenges that are being faced in the improvement of the condition and the different strategies for its control.
Severe Acute Malnutrition (SAM) and Nutrition Rehabilitation Centre (NRC)- Dr...Yogesh Arora
A presentation on severe acute malnutrition and nutritional rehabilitation center. Various preventive, promotive, and curative aspects of SAM are discussed in this presentation.
Stunting and Wasting in Children Under 2 in a Semi-nomadic Pastoralist Popula...CORE Group
CORE Group GHPC15
October 8, 2015
Concurrent Session: Factors Associated with Growth in the First 1,000 Days: Translating Evidence into Programs for Stunting, Wasting, and the Double Burden of Malnutrition
Integrating severe acute malnutrition into the management of childhood diseas...Malaria Consortium
Since December 2010, Malaria Consortium has been implementing an innovative approach to community management of severe acute malnutrition, together with an existing integrated community case management (ICCM) programme in South Sudan. This learning paper considers Malaria Consortium’s experience of this combined approach in a highly complex context and shows whether the management of severe acute malnutrition is an effective, acceptable and feasible component of ICCM programming.
The journey of low birth weight infant Khaled Saad
Previously known as ‘failure to thrive’ (FTT), also known as weight faltering
Infant or children whose current weight or rate of weight gain is significantly below that expected of similar children of the same age, sex and ethnicity
Can occur in both infants (< 1 year of age) and in children (> 1 year of age)
PRESENTATION GIVEN BY ME AT Central Food and Technology Research Institute (CFTRI), MYSORE WHICH ALSO FETCHED ME A PRIZE. THIS WAS ONE OF THE BEST AND PROUD MOMENTS IN MY CAREER
MALNUTRITION is more in India than in Africa . one in every three malnourished children in the world lives in India.
About 50% of all childhood death are because of malnutrition.
Stunting and Wasting in Children Under 2 in a Semi-nomadic Pastoralist Popula...CORE Group
CORE Group GHPC15
October 8, 2015
Concurrent Session: Factors Associated with Growth in the First 1,000 Days: Translating Evidence into Programs for Stunting, Wasting, and the Double Burden of Malnutrition
Integrating severe acute malnutrition into the management of childhood diseas...Malaria Consortium
Since December 2010, Malaria Consortium has been implementing an innovative approach to community management of severe acute malnutrition, together with an existing integrated community case management (ICCM) programme in South Sudan. This learning paper considers Malaria Consortium’s experience of this combined approach in a highly complex context and shows whether the management of severe acute malnutrition is an effective, acceptable and feasible component of ICCM programming.
The journey of low birth weight infant Khaled Saad
Previously known as ‘failure to thrive’ (FTT), also known as weight faltering
Infant or children whose current weight or rate of weight gain is significantly below that expected of similar children of the same age, sex and ethnicity
Can occur in both infants (< 1 year of age) and in children (> 1 year of age)
PRESENTATION GIVEN BY ME AT Central Food and Technology Research Institute (CFTRI), MYSORE WHICH ALSO FETCHED ME A PRIZE. THIS WAS ONE OF THE BEST AND PROUD MOMENTS IN MY CAREER
MALNUTRITION is more in India than in Africa . one in every three malnourished children in the world lives in India.
About 50% of all childhood death are because of malnutrition.
Growth denotes a net increase in the size or mass of tissues. It is largely attributed to multiplication of cells and increase in the intracellular substance. Development-specifies maturation of functions.
It is related to the maturaration and myelination of the nervous system and indicates the acquisition of a variety of skills for optimal functioning of the individual.
For adventurous travel blog please visit http://wilsontom.blogspot.com/
Nuova tappa dedicata all'approfondimento delle singole piattaforme: è la volta di Google+
Amato oppure odiato il social G+ continua la sua corsa migliorando la sua struttura, aggiungendo funzionalità e offrendoci un'esperienza "social" un pò diversa da quella del "nemico" Facebook.
Google+ è una piattaforma molto ricca, da scoprire e integrare all'interno delle proprie strategie per innamorarsi delle sue dinamiche e della sua facilità di utilizzo.
Ancora non ti ho convinto? Segui questo webinar, scoprirai tutto ciò che ti serve conoscere per iniziare ad usarlo davvero e metterne a frutto le dinamiche ;)
www.zincsaveskids.org
Zinc deficiency is a significant public health issue. Zinc supplements and fortification are effective and affordable ways interventions and can help prevent the deaths of 800,000 people annually. "Zinc Saves Kids" is an initiative of the International Zinc Association which supports UNICEF's zinc supplement programmes on the ground in Peru, Nepal, Brazil and in Africa.
Physical growth and cardiovascular health: a focus on stuntingInes Varela-Silva
Plenary talk presented at The 4th International Conference on Evolutionary Medicine: Health and Disease in Changing Environments (5-10 June 2018), Vilnius, Lithuania
Lecture held at the 4th Evidence-Based Neonatology conference, Nov 12 2017, in Hyderabad, India.
The lecture gives a short overview of the "fetal programming" theory, also referred to as the Developmental Origin of Health and Disease (DOHaD).
Factors Associated with Growth in the First 1,000 Days CHECKLEYCORE Group
CORE Group GHPC15
October 8, 2015
Concurrent Session: Factors Associated with Growth in the First 1,000 Days: Translating Evidence into Programs for Stunting, Wasting, and the Double Burden of Malnutrition
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
CDSCO and Phamacovigilance {Regulatory body in India}
The Vicious Cycle of Diarrhea and Malnutrition: Effect on Growth and Development Cognition, Obesity, Biomarkers, Pathogens
1. The Vicious Cycle of Diarrhea and Malnutrition:
Effect on Growth and Development
Cognition, Obesity, Biomarkers, Pathogens
Richard L Guerrant
Aldo AM Lima, Reinaldo Oria,
Jim Roche, Rebecca Scharf, Mark DeBoer, Jim Nataro,
Orleancio Azevedo, Noronha Diniz, Pranay Sinha, et al
Infectious Diseases and International Health
Centers for Global Health
University of Virginia-Federal University of Ceara-ICIDR-NIAID/FIC/FNIH
Charlottesville, VA-Fortaleza, Brazil
The Global Crisis of Childhood Diarrhea
PROGRAMME FOR GLOBAL PAEDIATRIC RESEARCH SYMPOSIUM
Boston - April 30, 2012
3. The Vicious Diarrhea-MN Cycle
Diarrhea
Inc. incidence +
Inc. duration
& severity
Malnutrition
Dec. Wt gain (short)
Dec. Ht gain (long)
4. Malnutrition increases incidence
and duration of diarrhea
>-3 WAZ <-3 WAZ %inc. p value
Episodes/2m 1.9 2.6 37% 0.001
Duration (d) 6.7 11.6 73% 0.004
Total d of D. 12.1 24.2 100% <0.001
•By Wilcoxon rank sum test
•Also valid for moderate MN (<90% HAZ) Schorling JB et al, Int J Epi 19: 728-735, 1990.
5. ECD /Enteric Infections Stunt Growth („60s-‟80s)
•Guatemala
•“Matagram” and dysentery/bpnuem Scrimshaw Taylor Gordon; Mata etal. Am J Clin Nutr24:249, 1971.
•ECD (not fever/pneumonia) stunts Ht 6.5%, irresp of feeding Martorell R et al. Am J Dis Child
129: 1296, 1975.
•Gambia
•ECD (not ARI) impairs Ht & Wt gains Rowland MG et al. Br J Nutr 37: 441, 1977.
•ECD (& ARI) <1yo/nonBF impairs Wt gains Rowland et al. Am J Clin Nutr 47:134, 1988.
•Mexico
•ECD (not ARI) impairs Wt gains to 10% @3yo Condon-Paoloni et l. AJPH 67: 651, 1977.
•Brazil
•ECD impairs Wt (32% @2wks), Ht (41% @ 3.5m) Guerrant et al. JID 148: 986, 1983.
•ECD blunts catchup growth & PD (not fever/pneumonia) stunts Wt & Ht Leslie J, de
Souza MA. Ch 15 in Edge of Development 1996; Schorling, Guerrant Lancet 335: 599, 1990; Moore et al Gastro 139:
156, 2011.
•Bangladesh
•ECD (not ARI) stunts Wt @ 2m & 2/10cm Ht @ 5yo, esp. Shigella, ETEC but irresp of
etiol. Black RE et al, Pediatr 73: 799, 1984.
6. “Matagram” showing that repeated diarrheal and
other illnesses pull children off their growth curves
Mata L. The children of Santa Maria Cauque. MIT Press, Cambridge MA. 1978.
7. Starting ok
WHZ but losing
WAZ at 3-24 months!
HAZ
Victora…Shrimpton,
Pediatrics 125: e473, 2010. Latin America
Africa
Pediatrics 107: e75, 2001. S.Asia
8. Diarrhea ablates catch-up growth
0.5
Weight gain (kg/month)
0.4
0.3
Weight for age <-3
Weight for age >-3
0.2
0.1
0
<15 15-30 31-45 >45
% of Days with Diarrhea
Schorling JB, Guerrant RL. Diarrhea and catch-up growth. Lancet 335: 599-600, 1990;
Petri et al. JCI 118: 1278, 2008; Guerrant et al. Nutr Rev 66: 487, 2008; Checkley et al. IJE 37: 816, 2008.
9.
10. Early childhood diarrhea (0-2 years old) impairs height-for-
age at 2-7 years old (8.2cm)
Moore SR et al, Int J Epi 30: 1457, 2001.
11. Multi-country analysis confirms that
diarrhea increases stunting (HAZ-2 <-2)
Every 5 episodes stunts 13%
(over incidence range of 3.6-13.4 episodes/child-yr!)*
* >5 episodes of diarrhea before 2yo
accounts for 25% of all stunting. Checkley et al, Int‟l J Epi 37: 816-30, 2008.
12. The Vicious Cycle of Diarrhea and Malnutrition:
Effect on Growth and Development
Cognition, Obesity, Biomarkers, Pathogens
•Vicious cycles of the diseases of poverty;
•ECD lasting stunting and cognitive impairment;
•Potential effects of early infections and stunting on
obesity/DM/MetS/CVD;
•Biomarkers/Pathogens-esis/Novel Interventions
13. Infectious Diseases Impair IQ The Economist, July 1, 2010.
When controlling for :
•GDP per capita;
• Education (WB lit.AVED)
•Temperature;
Nutritional deficiencies
correlation w IQ was
lost when ID removed
ie ID, not MN or
poverty may cause
the “Flynn Effect” of
IQ:Development
Eppig C, CL Fincher, R Thornhill.
Proc Biol Sci 277: 3801, 2010.
15. Albendazole Improves Physical and Cognitive
Development (hookworm, Ascaris &Trichuris)
•Kenyan schoolchildren had better Fitness, Growth
(W+L) and Appetite 2-4m after single Albendazole.
Stephenson L, et al. AJTMH 41: 78, 1989; TRSTMH 84: 277, 1990;
J Nutr 123: 1036, 1993.
•Jamaican schoolchildren had better short & long-
term memory (WISC digit span), Fluency and scanning
2 m after Albendazole x3d & arithmetic 10y w HAZ-2.
Nokes C, Grantham McGregor S, Bundy D, et al. Proc R Soc Lond B 247:
77, 1992 ; Chang SM et al J Child Psychol Psychiat 43:775, 2002.
16. Global Burden of Infections/MN:
Decreasing Mortality, but Increasing Morbidity
Of 7.6-10.6m Child Deaths/yr:
Diarrhea specific mortality
25
Mortality
rate per thousand
20
1955-1979
15
YLL 10
5
1982-1990
1990-2000
(Yrs of Life Lost) 0
<1y 1-4y 0-4y
Malnutrition Age group
53%
Diarrhea 15-18% (>3100/d)
Morbidity 6
Episodes per Person Year
5
YLD 178m stunted (HAZ<-2)
4
3
1955-1979
1980-1990
(Yrs Lost to Disability) MN is THE leading risk 2 1990-2000
1
20% of ALL children; factor for health loss! 0
32% DC children! 11-16% of all DALYs ; 0-5m 6-11m 1y 2y 3y 4y
Age group
35% of all <5yo DALYs!*
DALYs (Disability Adjusted Life Yrs)
Black , Bryce et al. Lancet 375: 1969, 2010;
*Black et al Lancet; 371:243, ‟08;
(YLL + YLD) Murray, Lopez Lancet 349: 1436, „97;
367: 1747, „06.
365:1147, 2005.
Kosek et al. Bull WHO 81: 197, 2003; .
Bhutta et al Lancet 371: 417, „08. JHPN 27:319, 2009.
Guerrant et al Tr Parasitol 18: 191, 2002.
17. Diarrhea increases stunting &
Stunting impairs Cognitive
Development & Schooling
Mod-sev HAZ-2yo 25-61% IQ z lower @ 8-11yo
(Philippines Nonverbal Intel. - Guthrie test; p<0.001)
•Both severity and timing dependent; only 1/3 catch up
•Partially reversible
•Compounded with indirect effects on schooling.
30% lower
IQ @ 11yo
Stunting impairs cognition, but schooling still helps
Stunting delays schooling Mendez M & Adair L. J Nutr 129: 1555-62, 1999.
18. Nutrition @ 0-2yo increases IQ and earning
Atole veg/prot suppl (2/4 Guatemalan villages ‟69-‟77)
(163kcal/11.5g protein vs 59kc/0prot “Fresco” -INCAP Martorell, et al)
•10% better Raven IQ
(AFTER adjusting for schooling)
Stein AD et al. Arch Ped Adolesc Med 162: 612-8, 2008.
•46% higher wages @ 25-42yo m
•8-20% higher reading, Raven, schooling f
(But not after 3yo!)
Hoddinott J et al. Lancet 371: 411-6, 2008.
19. Magnitude of lasting disability effects
from early childhood diarrhea (ECD):
1. Growth shortfalls (esp. HAZ-2; 8.2cm by 7yo)
HAZ-2 is the best predictor of human capital!
(schooling, economic productivity, offspring wt!)
Victora C. et al, 5 cohorts (Bz, Guat, India, Philipp, S Africa) Lancet 371: 340, 2008.
2. Fitness impairment (=17% decr. work prod.)
3. Cognitive impairment (c. 10 IQ points)
4. School performance (c. 1 yr)
(increased age at starting school and age-for-grade)
These effects >DOUBLE the global diarrhea DALYs.
Moore et al. Int J Epi 30: 1457, 2001. Guerrant DI et al. Am J Trop Med Hyg 61: 707, 1999.
Niehaus et al Am J Trop Med Hyg 66: 590, 2002. Guerrant et al Tr Parasitol 18: 191, 2002. Lorntz et al PIDJ 2006.
20. Low HAZ-2 correlates with:
•Adult stunting
•Less attained schooling (1y=12-14% lifetime earnings)
•Reduced economic productivity (Monthly income)
•Lower offspring birthwt (in females)
•Hi glucose, BP, lipids (p BMI controlled for,
implicating subsequent wt gains; ?Barker hypothesis;
“Thrifty epigenotype” & genetic „canalization‟)
HAZ-2 is the best predictor of human capital!
(schooling, economic productivity, offspring wt!)
Victora C. et al, 5 cohorts (Bz, Guat, India, Philipp, S Africa) Lancet 371: 340, 2008.
21. The cognitive deficit most impaired with diarrhea
is Semantic Fluency (as in Alzheimer‟s Disease)
(and ApoE4 protects children‟s cognition with heavy diarrhea; “thrift allele”)
125
R2 = 0.135, p=0.012
100
Test of
Non-verbal
Intelligence-III
quotient
75
IQ at
6-9yo
50
0 5 10 15 20 25 30 Guerrant DI et al. Am J Trop Med Hyg 61: 707, 1999. Niehaus et al.
Diarrhea rates at 0-2yo AJTMH 66: 590, 2002. Patrick et al. Child Neuropsych 11: 233, 2005.
Oria R, Patrick P, Lima A, et al Pediatr Res. 57: 310, 2005.
23. Most (>75%) of Human Brain Growth & Development
Occurs in the First 2 Years of Life
Human brain Human brain wt/age
growth
Human postnatal visual cortex dendritic tree
birth 15 m 2 yo
+ only 1 opportunity for neuronal connections or „forever lost‟
24. Importance of a Healthy Gut in Early Childhood
To full growth and healthy development:
Key in first 2 years of life, because that‟s when:
1.Synaptic “tracks” are laid;
2.Most vulnerable
Mendez M & Adair L. J Nutr 129: 1555-62, 1999.
Stein AD et al. Arch Ped Adolesc Med 162: 612-8, 2008.
Hoddinott J et al. Lancet 371: 411-6, 2008.
25. Might ECD/Stunting also risk Obesity?!
[Bad water colliding with bad diets]
Of 117/532 Adults in Maceio Slum (NE Brazil) who were
stunted:
• 30% (vs 23.6% of nonstunted) were overweight or obese
vs
• 16% (vs 23% of nonstunted) were underweight
?via increased cortisol:insulin or decreased IGF-1 levels
??Transgenerational epigenetic DNA methylation/silencing
Sawaya AL et al. Nutr Rev 62: S127-133, 2004;
Varela-Silva et al. Coll Anthropol 1: 39-46, 2007.
26. Low HAZ-2 correlates with:
•Adult stunting
•Less attained schooling (1y=12-14% lifetime earnings)
•Reduced economic productivity (Monthly income)
•Lower offspring birthwt (in females)
•Hi glucose, BP, lipids (p BMI controlled for,
implicating subsequent wt gains; ?Barker hypothesis;
“Thrifty epigenotype” & genetic „canalization‟)
HAZ-2 is the best predictor of human capital!
(schooling, economic productivity, offspring wt!)
Victora C. et al, 5 cohorts (Bz, Guat, India, Philipp, S Africa) Lancet 371: 340, 2008.
27. Long-term epigenetic effects
& evolution of imprinting
(Dense cytosine methylation of CG dinucleotides silences promoters)
• Heavy LEP promoter methylation occurs during
postzygotic development in mice & humans.
Stoger R. Epigenetics 1: 155, 2006.
Stoger R. BioEssays 30: 156, 2008.
• LEP (and IGF2, IL10, ABCA1, GNASAS, MEG3) methylation greater in
WBC of periconceptually DHW exposed vs sibs.
Tobi, Stein et al. Hum Mol Gen 18: 4046, 2009.
28. Early MN Later Obesity & Heart Disease
• 300k 19yo men more obese if mothers pregnant
in Dutch Hunger Winter of 1944-5.
Ravelli GP et al. NEJM 295: 349, 1976.
Whitelaw NC & Whitelaw E. Hum Mol Genet. 15: R131, 2006.
• 7845 women in DHW Famine (@10-17yo) have
27% more HD.
vanAbeelen A et al. BBC News & Europ Heart J. Aug 25, 2011.
• Early Childhood Stunting (or lo BWt) has 29-65%
greater Abd obesity (waist:hip/eaHAZ-3)
Schroeder, Martorell, Flores. AJEpi 149: 177, 1999.
29. Chronic consequences of enteric infections:
Physical and cognitive development
Margolis „10
Niehaus „02
Pinkerton „11
Eppig „10
Mendez, Adair „99
Moore ‟01 Cognitive
ECD Checkley „08 Early Stein, Martorell „08
Sinha P „11
Impairment
Enteropathy Stunting
(Early Childhood HAZ-2 Van Abeelen ‟11
Diarrhea) Victora ‟08 ; Martins 06;
Sesso 04; Ferreira „09
BMI-2
Preg/LBWt
Grillol 05;
Barker NEJM „05
Adult
HD/HT
Schroeder „99
Ferreira „01, „09
Obesity DM/GiTT
Bhargava „04
Ravelli (DHWinter) „76 Abd (waist:hip) Met. Synd
Barker „86, „88, „90 , ‟92
Fall ‟08 HiLDL; LoHDL
Victora „08
Poor Later
childhood obesity Poor
Later
growth childhood
2h G>140@30yo CHD<64yo Z growth
obesity
1.5k Delhi 8k Norway
BMI
Bhargava „04 Barker „05
31. Markers and Impact of Environmental Enteropathy
Assessing: Urine Stool Blood
Barrier/Abs Damage: L/M ** Alpha1-AT EndoCAb**
Cr ?Zonulin* Zonulin
?Intestinal FABP* ?Intestinal FABP* Intestinal FABP
Inflammation: MeBlue Microscopy
(Hemoccult)
Lactoferrin (nonBF)**
MPO
Nitric Oxide (ie IL-8 et al
nitrates+nitrites) * ?IL-8 mRNA*
?Calprotectin*
??Calprotectin mRNA* **Documented to
be associated
?Neopterin* with stunting.
?SAA3*
Repair: ?Citrulline* ?Citrulline *Research
(?Reg-1*) questions.
Small Bowel Overgrowth Lactulose Breath Test
Tissue Biopsy +quantitative culture Gut Integrity
METABONOME Meeting-Seattle,
Field History: Hx of ProD >7d** December, 2010
32. Prolonged or Persistent Diarrhea
(ie any diarrhea >7d)
signals heavy diarrhea burdens and
weight and height growth shortfalls;
ie.
provides a “field biomarker” for
impending malnutrition!
Moore, Lima et al. Gastroenterol. 139: 1156, 2010.
33. Emerging causes of Persistent Diarrhea/MN
in Fortaleza, Brazil
Cases Controls
(n=127) (n=331)
Enteroaggregative E. coli
AA probe + 32%* 14%
AA probe - 36* 17
Cryptosporidium 25** 5
Giardia lamblia 21** 8
Ricci et al. Nature S1: 29, 2006
*P<0.05; **P<002 Fang et al J Ped Gastro Nutr 1995
Koopmans et al Ped ID J 16:504, 1997
Lima et al. J Infect Dis 181: 1643, 2000
Steiner T et al. J Infect Dis 177: 88, 1998.
34. Emerging causes of Persistent Diarrhea/MN
in Fortaleza, Brazil
Cases Controls
(n=127) (n=331)
Enteroaggregative E. coli
(-0.76 HAZ; p<0.05; Steiner JID 177: 88,‟98
EAEC w MN in MalED CC Lima „12)
AA probe + 32%* 14%
AA probe - 36* 17
Cryptosporidium 25** 5
(Checkley „97; ‟98; Agnew JID 177: 754,„98)
Giardia lamblia 21** 8
(Newman TMIH 6: 624, ‟01 Sx w MN; PD>AD) Ricci et al. Nature S1: 29, 2006
Fang et al J Ped Gastro Nutr 1995
Koopmans et al Ped ID J 16:504, 1997
Lima et al. J Infect Dis 181: 1643, 2000
*P<0.05; **P<002 Steiner T et al. J Infect Dis 177: 88, 1998.
35. Evidence for lasting disability effects
from early childhood diarrhea/enteric infections*
Growth shortfalls (esp. HAZ-2; 8.2cm by 7yo)
•Crypto Infections increase diarrhea morbidity and nutritional shortfalls to 18m
[Agnew 98; Lima 00; Newman 99]
•Crypto infections +diarrhea = dec. wt gain @1m [Checkley 97]
•Crypto infections <6m/stunted = .95-1.05 cm deficits @1y [Checkley 98]
•EAggEC infections + inflammation = growth shortfalls [Steiner 98]
•Diarrrhea<2yo = 3.6cm stunted @7yo (8.2cm w helminths) [Moore 01;
+ Checkley et al, 08]
Fitness impairment (=17% decr. work prod.)
•Albendazole =7% inc. HST @4m [Stephenson 93]
•Diarrhea or Crypto <2yo = 4-8% dec. HST @4-7yo [Guerrant 99]
•4.3% inc. HST = 16.6% inc. work prod. [Ndamba 93]
Cognitive impairment (c. 10 IQ points)
•Diarrhea <2yo dec. WISC coding/digit @5-9yo [Guerrant 99]
•Diarrhea <2yo dec. TONI @6-10yo [Niehaus 02]
•Giardia or stunting = 4-10 pts dec. WISC-R @9yo [Berkman 02]
School performance (c. 1 yr)))
•Diarrhea <2yo = inc. AASS; AFG [Lorntz 06; Guerrant 02]
* Petri et al JCI 118: 1277-1290, 2008; Guerrant et al Nutr Rev 66: 487-505, 2008.
36. Cryptosporidium, EAEC, Giardia
or Intestinal Inflammation
Stunt Growth and/or Psychomotor Development
•Fecal neopterin (inflammation) in 72 children
followed 15m in rural Gambia had impaired long-term
ht and wt gains (r=-0.29 and -0.36; p<0.001)
[not Giardia or L/M]
Campbell DI et al. J Ped Gastro Nutr 39: 153, 2004.
37. ECD or Giardiasis Stunt Growth and Cognition
•Stunting or Giardia Peru <2yo WISC-R IQ @ 9yo
Berkman DS et al. Lancet 359: 564, 2002.
•Of 160 Children <5yo in Turkey, those w Giardia were stunted
(OR=7.7) and had psychomotor impairment (OR=2.7)
Simsek Z et al. J Trop Pediatr 50: 90, 2004.
•Giardia Egypt <4yo had cognitive development if E4-
Yahya RS et al. Internet J Parasit Dis 4:1, 2009.
•Heavy ECD or Giardia <2yo Sem. Flu @ 6-12yo E4-
Newman TMIH 6: 624, „01 PD; Patrick PD et al. Child Neuropsych 11: 1-12, 2005
Oria R et al. Ped Res 57: 310, „05; Bz J Biol Res 43: 249, 2010.
•Giardia 6-13yo Iran had WISC Fluency, Span (indep of WAZ)
Partovi F et al. Iran JPH 36: 73, 2007.
•Asxy Giardia Salvador <4yo have stunting 1y later
Prado MS et al. Parasitol 131: 51, 2005.
•Sx Giardia S India predict wasting and cognition@ 3yo
Ajjampur SSA et al. Trop Paediatr 31: 203, 2011.
Guerrant, Oria, Moore, Scharf, Lima “ 201, 2011.
38. Enteroaggregative E. coli (EAEC) causes
Persistent Diarrhea, Intestinal Inflammation, Growth Shortfalls
•EAEC is associated with 36% of PD; 30-74% w HIV
•EAEC-PD has elevated fecal LF, IL-8, IL-1 [Fli-C; TLR5]
•EAEC-no D. also had elevated LF & Growth Shortfalls
Steiner T et al JID 177: 88, 1998; Wanke et al JID 178: 185, 1998;
Samie A et al. 77: 142, 2007; Steiner T et al JCI 105: 1769, 2000.
Nataro et al and Steiner et al CID: 2006.
EAEC Turista (26%)
Only with IL-8 -251 AA or AT Polymorphism
•0/23 w EAEC Diarrhea had TT vs 9-18% of 46 others without Sx
or without EAEC (OR = 208; p<0.01)
•Also those with -251 AA had greater fecal IL-8 (vs AT or TT;
p<0.01) Jiang ZD et al. JID 188: 506, 2003.
39. MalED Case-Control Site, Fortaleza, Ceará, Brazil
•Serves 313
km2 ; 13km
from UPC
•21k children IPREDE Nutrition Clinic, Fortaleza
•2000 new
children/yr
•30% of <3yo
have HAZ <-2
n=380
children
enrolled
Aldo Lima, Alvaro Madeiro, Sulivan Mota, et al. 2010-12.
40. Brazil case control: EAEC with MN
Microorganism Control Cases * p values Total
N (%) N (%) N (%)
EPEC 3/62 (4.8) 1/88 (1.1) ns 4/150 (2.7)
aEPEC 1/62 (1.6) 5/88 (5.7) ns 6/150 (4)
EAEC 4/62 (6.5) 22/88 (25) p = 0.0147 26/150 (17.3)
EHEC 3/62 (4.8) 3/88 (3.4) ns 6/150 (4)
EIEC 5/62 (8.1) 8/88 (9.1) ns 13/150 (8.7)
ETEC 2/62 (3.2) 4/88 (4.5) ns 6/150 (4)
Campylobacter 14/70 (20) 12/104 (11.5) ns 26/174 (14.9)
Adenovirus 0/42 (0) 1/72 (1.4) ns 1/114 (0.9)
Astrovirus 0/42 (0) 1/72 (1.4) ns 1/114 (0.9)
E. histolytica 2/38 (5.3) 2/63 (3.2) ns 4/101 (4)
Giardia 7/38 (18.4) 12/63 (19) ns 19/101 (18.8)
Cryptosporidium 2/38 (5.3) 1/63 (1.6) ns 3/101 (3)
EPEC: enteropathogenic E. coli; EHEC: enterohemorragic E. coli; EAEC: enteroadherence E. coli (aaiC + aatA);
EIEC: enteroinvasive E. coli.
Case: child <-2 WAZ; and control: >-1 WAZ; * Fisher‟s exact test. Aldo Lima, A Havt et al 2011.
41. Cryptosporidiosis impairs growth:
•Even “Asyx” (63 vs 37%) 162-342g less @3m
•Stunting (persisting @ 1y) if:
•Infection @ <5m (Agnew <1y 1-2 Z @ 2yo)
•Stunted @ time of infection
•Also in Africa (Molback) if <1yo, no catchup
• And Asia (Ajjampur) Checkley et al. Am J Epi 145: 156, 1997;
multiple Crypto common “ “ 148: 497, 1998;
Agnew et al. JID 177: 754, 1998;
and lower HAZ-2 Molback et al. Am J Clin Nutr. 65: 149, 1997;
Ajjampur et al. AJTMH 83: 1110, 2010.
42. Murine model of weanling malnutrition
& Cryptosporidium infection
C57BL/6J mice at 7 days
old. Note the difference
in the body weight between
the nourished and
malnourished mice.
4h of separation
8h of separation
12h of separation
C57BL/6J Wild types
4 5 6 = Crypto infection 14
Age (days)
43. Cryptosporidium infection causes Malnutrition
ie. MN is an ID AND
MN worsens Crypto infection
275 NC (n=11)
250 NI 106 (n=16)
% initial weight (g)
MC (n=10)
225 41%
loss MI 105 (n=14)
200 MI 106 (n=16)
175 further 48% loss
150
125
**
100
**p<0.01 vs all groups by
6 7 8 9 10 11 12 13 14 ANOVA‟s Bonferroni test
Age (days)
Coutinho, Oria, Meton, Sevilleja, et al. J Parasitol 94: 1225, 2008.
44. Synergistic effects of malnutrition and
Cryptosporidium infection on ileal architecture
(H&E; 10X; at 14do; 8d p infection)
Nourished Non-infected Malnourished Non-infected
Nourished Infected Malnourished Infected
Coutinho, Oria, Meton, Sevilleja, et al. J Parasitol 94: 1225, 2008.
45. Malnutrition is associated with a 1 to 2.3 log (ie 10 to
200-fold) heavier infection by fecal shedding or in colon
or ileum in 107 Cryptosporidium-infected mice
at peak infection (d8)
2.50
2.00
log Mean (# of parasites / mg of ileal tissue)
log Mean (# of parasites / mg of stool)
2.00
1.50
1.50
1.00
1.00
log Mean (# of parasites / mg of colonic tissue)
2.00
0.50
0.50 1.50
0.00
1.00 -0.50
0.00
MN (n=12) N (n=14) MN (n=6) N (n=3)
Group Group
0.50
Error bars: +/- 1 SE Error bars: +/- 1 SE
Fecal Shedding 0.00
Parasites/gm ileum
(MN = 1.55 vs N = 0.54 MN (n=7) N (n=3)
(MN = 2.02 ± 0.11 vs N = -0.25 ± 0.13,
log/mg; N=26 mice in 3 paired Group
Error bars: +/- 1 SE
n=9 mice, p < 0.001)
experiments; p=0.015)
Parasites/gm colon
(MN = 1.79 vs N = -0.14, n=10 mice, p= 0.001)
Detected by Real-time PCR Coutinho, Oria, Meton, Sevilleja, et al. J Parasitol 94: 1225, 2008.
46. Cryptosporidium causes and worsens MN
Unexcysted oocysts in weaned, 2% protein MN mice
N, Uninfected P<0.03
14%
P<0.05
MN MN-Infected
N, infected
MN, Uninfected
23%
P<0.03
MN, infected P=0.029
Infection @ d58
Costa L, Noronha, Roche, et al. JID 205: 1464, 2012.
47. “Peace Corps Gut”
Normal PCV w Diarrhea and Malabsorption (d-xylose & B12)
40% (of 114) had d-xylose <5g
52% (of 23) had low Schilling B12
Lindenbaum et al. AIM 65: 1201, 1966.
Bx nl in 2/17 (12%); 8 had mild ;7 moderate “jejunitis”
48. Candidates to help “repave”
the small bowel absorptive
tennis court
(every 3 days!)
Normal HIV+ Patient with Cryptosporidium infection
Yamada et al. (1995) Conlon et al. (1984)
Zinc, Vitamin A, Glutamine, Alanylglutamine, Arginine, ?ApoE
peptides, targeted antimicrobials, adjuvants, vaccines
Carneiro, Bushen, Brito, Lima, Guerrant. Curr. Infect Dis Rep. 5: 114, 2003.
Bushen et al. CID 38: 1764, 2004; Lima N et al. J Pediatr Gastroent Nutr 44: 365, 2007.
Ueno… Moore. Am J Physiol GI Liver Physiol 301: 2011. Castro I et al Nutrition, 2011.
50. Diarrhea (Ac, Pro, PD) predisposes to
growth decrements (WAZ or HAZ)
*
Moore, Lima et al. Gastroenterol. 139: 1156, 2010.
51. Glutamine and Ala-Gln ORRT
improve the repair of intestinal epithelium
in IEC6 cells and in
children and HIV+ pts with diarrhea.
Control with Glutamine with Ala-Gln
Brito, Carneiro, Lima, Guerrant. 2004.
Carneiro, Bushen, Brito, Lima, Guerrant. Curr. Infect Dis Rep. 5: 114, 2003.
Bushen et al. CID 38: 1764, 2004; Lima N et al. J Pediatr Gastroent Nutr 44: 365, 2007.
Ueno… Moore. Am J Physiol GI Liver Physiol 301: 2011.
52. Diarrhea impairs Cognitive
Development & Growth
independently
ECD0-2, HAZ2 or WAZ2 predicts TONI & Coding @ 6-12yo
(Brazil cohort of 131 followed from birth; UV p<0.05)
•Excluding household income, maternal education,
child sex, birth wt, breastfeeding
•ECD remained a predictor of IQ even after adjusting
for HAZ and WAZ (multivariate p< 0.006-0.029)
Pinkerton, Oria, Lima, Patrick et al. 2012.
53. Prolonged and persistent diarrhea account for only
100%
17% of episodes, yet half of all diarrhea days
AND predict heavy diarrhea burdens and growth shortfalls!
83%
Acute (<7d)
75% Prolonged (7-13d)
Persistent (≥14d)
% of diarrhea
morbidity
50%
50%
25% 25%
25%
12%
5%
0%
By episodes By days
Moore, Lima et al. Gastroenterol. 139: 1156, 2010.
54. Proposed model for Ala-Gln coupling to EGFR signal
transduction during enteric infections and malnutrition.
Moore S, Polk B et al. 2009.
55. AlaGln improves Wt, morphometry, apoptosis &
proliferation in MN weaned C57Bl/6 mice
Ueno… Moore.
Am J Physiol
GI Liver
Physiol 301:
2011.
56. AlaGln improves barrier function (lactulose
excretion) and weight gains in malnourished
children in Brazil
* p < 0.05
0.4 A *
Peso-para-Estatura
0.3
Cumulativo
WHZ
Escore z
Gain
0.2
0.1
0.0
Glicina Alanil-Glutamina
Lima N et al. J Pediatr Gastroent Nutr 44: 365, 2007.
57. Gln or Ala-Gln enhance absorption
(even with Crypto infections when Glucose fails)
3 3
Ringers Control Ringers Control
10 mM Gln 10 mM Gln
10 mM AlaGln 2 10 mM AlaGln
2
JnetNa
JnetNa
1
1
0
0 n=9 n=9 n=6
n=18 n=18 n=6 Cryptosporidium
Control Infected
Alanyl-glutamine compares favorably to glutamine
in Control and Crypto-infected calves in Ussing
Chambers in driving net sodium absorption
Blikslager et al, Am J Physiol 281: G645, 2001.
58. Another vicious cycle: Barrier disruption & Inflammation
TJ (TNF, MLCK)
(lo cap; nonselect)
Claudin, Occludin,
ZO1, actin,
myosin
AJ (Th2, IL13)
(hi cap; ionselect)
E-cadherin, Lunn P. Proc Nutr Soc
abCatenin,
myosin
59: 147, 2000.
Turner JR Nature Rev,
Immunol 9: 799, 2009.
Salazar-Lindo E....
D Brewster…
A Fasano....P Tarr.
JPGN 39: S662, 2004.
Sears C. Clin Micro
Rev 22: 349, 2009.
59. Urine Metabonome in MN vs Control Children
showing increased NAG, DMA, DMG; less Mannitiol
(by NMRS and PLS-DA coefficient plot)
Projection to Latent Structure-Discriminant Analysis
Cases vs
Control s
p=0.0248
n=75
CA2-3
Swann J,
Lima AAM,
et al. 2011.
60. Enteroaggregative E. coli (EAEC)
Infection Impairs Growth
& MN worsens infection
DMEM / HS (Nourished Control) n=11
EAEC-JM221 (Nourished infected) n=12
EAEC-JM221 (Malnourished infected) n=7 EAEC
29% less
p<0.03 p d8
Further 32% less
with MN
P<0.02
**
Peak shedding = 102-2.8 Nourished/ 103.1-7.5 Malnourished
Roche, Cabel,
Sevilleja,
Nataro et al,
JID 202: 506,
2010.
61. Induces
Glutamine HSP70, which:
•Attenuates iNOS, IL-6, IL-8
(in rat CP bypass)
•Protects against neurodegeneration
(in spinocerebellar degeneration, SCA-1 mice)
Hayashi Y et al. Circ. 106: 2601, 2002.
Cummings CJ et al. Hum Mol Genet 10: 1511, 2001.
62. Cryptosporidium and Giardia genotypes in
Brazil and South Africa
•C. hominis predominates in NE Brazil with:
greater shedding, lactoferrin & growth shortfalls
Bushen, Lima et al. TRSTMH, 2006.
•C. hominis predominates in Limpopo, S. Africa;
assoc. w diarrhea (57%); lactoferrin (59%)
Samie et al. Expt Parasitol 114: 314, 2006.
•74% of Giardia are Assemblage B, with
greater shedding (3.6 v 1.4 x 105/ml); lactoferrin
(especially with first infection; 74 40 20%; also longer)
Kohli, Lima et al., TRSTMH 102: 718-725, 2008.
63. Conclusions (re Crypto and MN)
•Crypto infections, +diarrhea, ProD or PD impair growth in
young children (or mice);
•Likely via disrupted intestinal mucosal function (L/M; V/C);
•MN worsens Crypto (in stunted children or MN mice), thus
completing the vicious cycle (that also impairs cognitive
development, with an “Alzheimer-like” deficit).
•ApoE4 protects against these deficits only in children with
heavy diarrhea burdens.
•ApoE4/4 targeted transgenic Eko mice grow better and have
less barrier disruption & infection.
•Arginine, like ApoE4, protects mice and may protect children
from the vicious diarrhea-MN cycle.
64. Disruption of Intestinal Barrier Function in Children
with Acute and Persistent Diarrhea in Fortaleza, Brazil
0.8
**
0.7
0.6
*
0.5
Mean
Lactulose:
Mannitol 0.4
Excretion
Ratios 0.3
0.2
0.1
0
Control AD PD
n=20 n=18 n=2
[vs controls: *p=0.001; **p<0.001]
Guerrant, Lima, Barboza, et al Adv Exp Med Biol 473:103-11, 1999.
Barboza et al BrasJ Med Biol Res 32:1499-1504, 1999.
65. EndoCAb correlates with disrupted intestinal
barrier function and with stunted growth
Campbell DI, Elia M, Lunn PG. J Nutr 133:1237, 2003.
Petri, Ahmed, Haque et al 2010.
66. Enteroaggregative E. coli (EAEC) causes
Persistent Diarrhea, Intestinal Inflammation, Growth Shortfalls and
is the Leading Bacterial Enteropathogen in US
•EAEC is associated with 36% of PD; 30-74% w HIV
•EAEC-PD has elevated fecal LF, IL-8, IL-1
•EAEC-no D. also had elevated LF & Growth Shortfalls
•EAEC filtrates induce IL-8 release in Caco-2 cells.
•EAEC Fli-C (unique flagellin) cloned/sequenced is
responsible for the IL-8 release.
•EAEC signif assoc with 4.5% diarrhea in Baltimore
and New Haven (vs 2-3% Cj, Salm; 10-12% Rota, Noro)
Steiner T et al JID 177: 88, 1998; Wanke et al JID 178: 185, 1998;
Samie A et al. 77: 142, 2007; Steiner T et al JCI 105: 1769, 2000.
Nataro et al and Steiner et al CID: 2006.
67. HAZ correlates with Grades and Rank
(among 242 college schoolgirls in S. India)
r2=.037 r2=.030
p =.003 p =.007
(Independent of also significant # siblings, paternal education.)
Pranay Sinha, B.S. Ramakrishna, et al. August, 2011.
68. Infant MN CVD
Barker Hypothesis
Barker D. et al. Lancet 1986, „89, ‟90.
Hertfordshire & Southampton, UK
70. Infants with ProD are high risk
for future episodes of PD
(+) Prolonged Diarrhea
prior to age 1 year
*
% of children
with p=0.002
Log-rank test
Persistent
Diarrhea
No Prolonged Diarrhea
prior to age 1 year
Age (months)
Moore, Lima et al. Gastroenterol. 139: 1156, 2010.
71. Cryptosporidium: A Leading cause of
Prolonged and Persistent Diarrhea &
Growth Shortfalls
% w Crypto P (vs no D)*
•Persistent Diarrhea (n=71) 23.9%* 0.0002
•Prolonged Diarrhea (n=98) 12.2%* 0.018
•Acute Diarrhea (n=402) 11.4%* 0.0043
•No Diarrhea (n=289) 5.2% -
Also Giardia with 20.5% of 88 with PD (p=0.0003); and fecal WBC or LF in 43-77% (p<0.02).
Lima AAM et al. JID 181: 1643, 2000.
Moore S et al. Gastroenterol 139: 1156, 2010.
72. Long-term Consequences of
Cryptosporidium Infection
•Malnutrition Sallon ‟88; Sarabia-Arce ‟90; Checkley ‟99; (Peru)
Lima ‟92; (Brazil); Molback ‟93; ‟97; (G-Bissau)
•Even Asxy Crypto Stunting Checkley ‟97; (Peru)
C. hominis > parvum, c 2x shedding Bushen ‟07 (Brazil))
(3.5x106); LF; longer growth delay
•Early Diarrhea or Crypto DI Guerrant et al „99
(Brazil))
Fitness + Cognitive
impairment 4-7y later
•Reactive Arthritis/Reiter‟s Hay ‟87; Ozgul ‟99; Shepherd
‟89; Cron ‟95; Hunter „04
Chalmers & Davies Expt Parasitol 124: 138, 2010.
73. ApoE4 Upregulates an
Arginine-selective Cat-1 Transporter
•Transgenic mice expressing the human APOE4
allele have expression of mRNA for the
constituitive Arg selective y+ transporter (Cat1) in
microglia.
•Hence NO (not iNOS) and cell proliferation.
Colton, et al. Neurobiol Aging 23: 777, 2002
Czapiga & Colton. J Neuroimmunol. 134: 44, 2003.
74. Arginine improves wt gain & reduces ileal
Cryptosporidium infection by over 10-fold by both iNOS
& arginase-dependent pathways
Oocyst shedding in Ileum
200000
* p < 0.05
175000
* p < 0.05
150000
Oocysts per mg of tissue
* p < 0.05
125000
100000
75000
50000
25000
0
PBS Arg 200mM Arg 100mM Arg 200mM + Arg 200mM +
L-NAME 20mM BEC 2.2mM
L-NAME = NG-nitroarginine methyl ester (blocks iNOS);
BEC = S-(2-boronoethyl)-L- cysteine (blocks Arginase) Castro I. et al. Nutrition, 2012.
75. MN-Infected ApoE4/4ki Mice have better growth and
Villus/Crypt Architecture, and shed less Cryptosporidia
Post-infection
110
% of Weight
105
* # ApoE 4/4 MNI (n=16)
WT MNI (n=13)
100 ApoE KO MNI (n=14)
95
0 1 2 3 4 5 6 7
Days
* p<0.05 ApoE TR 4/4 MNI vs Wild type MNI
# p<0.0001 ApoE TR 4/4 MNI vs ApoE KO MNI
Shedding
p<0.05
10 6 p<0.05
Wild type MNI (n=12)
p<0.05 ApoE KO MNI (n=12)
p<0.05
nº parasites/mg of stool
10 5 ApoE 3/3 TR MNI (n=8)
p=0.05
ApoE 4/4 TR MNI (n=17)
10 4
10 3
10 2
1 3 5 7
Groups
Apoe4 mice had no shedding on day 7 De Azevedo, Oria, et al. 2012.
76. Recurrent diarrhea impairs height
and weight gains
Ht gain (cm) Wt gain (kg)
No recurrent diarrhea 1.74 cm 0.44 kg
Recurrent diarrhea* 1.38 cm** 0.25 kg***
* >30% prevalence over subsequent 2m
** 21% less; p=0.1
*** 43% less; p=0.01
Schorling & Guerrant. Diarrhea and catch-up growth.
Lancet 335: 599-600, 1990.